Ikarian Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Hold |
0
| – | – | – | 145 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 118 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 104 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 109 |
|
2023
Q3 | – | Sell |
-75
| Closed | -$17.3K | – | 105 |
|
2023
Q2 | $17.3K | Hold |
75
| – | – | ﹤0.01% | 80 |
|
2023
Q1 | $18.2K | Hold |
75
| – | – | ﹤0.01% | 88 |
|
2022
Q4 | $21.8K | Buy |
+75
| New | +$21.8K | 0.01% | 64 |
|
2022
Q1 | – | Sell |
-23,700
| Closed | -$2.01M | – | 168 |
|
2021
Q4 | $2.01M | Hold |
23,700
| – | – | 0.3% | 37 |
|
2021
Q3 | $1.89M | Buy |
23,700
+46
| +0.2% | +$3.67K | 0.13% | 69 |
|
2021
Q2 | $2.3M | Hold |
23,654
| – | – | 0.19% | 77 |
|
2021
Q1 | $2.77M | Hold |
23,654
| – | – | 0.09% | 84 |
|
2020
Q4 | $2.63M | Hold |
23,654
| – | – | 0.12% | 63 |
|
2020
Q3 | $2.81M | Sell |
23,654
-18,900
| -44% | -$2.24M | 0.2% | 44 |
|
2020
Q2 | $4.82M | Buy |
42,554
+2,220
| +6% | +$251K | 0.38% | 24 |
|
2020
Q1 | $2.69M | Sell |
40,334
-4,436
| -10% | -$296K | 0.2% | 30 |
|
2019
Q4 | $4.08M | Buy |
+44,770
| New | +$4.08M | 0.66% | 8 |
|